Results 51 to 60 of about 2,097 (184)
El Derecho a la Salud no entiende de tiempos
La justicia de la provincia de Córdoba hizo lugar al pedido de una medida cautelar autorizando el 100% de la cobertura del medicamento TRIKAFTA para el tratamiento de fibrosis quística.
Nadia Virginia Copello
doaj +1 more source
Abstract Vibrio fischeri is a model mutualist for studying molecular processes affecting microbial colonization of animal hosts. We present a detailed protocol for a barcode sequencing (BarSeq) approach that combines targeted gene deletion with short‐read sequencing technology to enable studies of mixed bacterial populations. This protocol includes wet
Hector L. Burgos, Mark J. Mandel
wiley +1 more source
ADULT-ONSET MUCOVISCIDOSIS: LONGER SURVIVAL OF PATIENTS IN MOSCOW AND MOSCOW REGION
Aim. To estimate survival median and its changes, number of patients over 18 years of age for 1991—2000 and 2001-2010 for 20-year period (1991-2010), to elucidate factors affecting survival for 2001—2010 in mucoviscidosis children living in Moscow and ...
S A Krasovsky +13 more
doaj
Clinical, nutritional and spirometric evaluation of patients with cystic fibrosis after the implementation of multidisciplinary treatment [PDF]
OBJETIVO: A fibrose cística (FC) é uma doença hereditária, multissistêmica e crônica, para a qual é importante uma abordagem multidisciplinar. O objetivo deste estudo foi mostrar a evolução de um grupo de pacientes com FC após a implantação desse tipo de
Almeida, Giseli Barbiero de +5 more
core +1 more source
An Efficient Low‐Cost Device for Sampling Exhaled Breath Condensate EBC
Exhaled breath condensate (EBC) is not simply distilled water but contains molecular biomarkers that are indicators for the health status of a person, typically in the case of lung diseases. A user‐friendly collection device has been designed that samples up to 2 mL of EBC in just 5 min thanks to utilizing materials with task‐specific thermo‐physical ...
Mehran Khorshid +8 more
wiley +1 more source
The Challenges and Promises of New Therapies for Cystic Fibrosis [PDF]
Therapeutic intervention in cystic fibrosis (CF) remains a challenge, partly because of the number of organs and tissues affected by the lack of a functional cystic fibrosis transmembrane conductance regulator (CFTR) protein.
Pier, Gerald B.
core +1 more source
Abstract Microbiome sequencing is at the forefront of health management development, and as such, it is becoming of great interest to monitor the microbiome in the aquaculture industry as well. Oxford Nanopore Technologies (ONT) platforms are gaining popularity to study microbial communities, enabling faster sequencing, extended read length, and ...
Giulia Zarantonello, Argelia Cuenca
wiley +1 more source
Clinical experience with amikacin, a new aminoglycoside antibiotic [PDF]
CITATION: Theron, F. P. & De Kock, M. A. 1977. Clinical experience with amikacin, a new aminoglycoside antibiotic. South African Medical Journal, 51(21):746-8.The original publication is available at http://www.samj.org.za[No abstract available]Publisher’
De Kock, M. A., Theron, F. P.
core
In Vitro Assessment of Cardiac Fibroblast Activation at Physiologic Stiffness
Abstract Cardiac fibroblasts (CF) are an essential cell type in cardiac physiology, playing diverse roles in maintaining structural integrity, extracellular matrix (ECM) synthesis, and tissue repair. Under normal conditions, these cells reside in the interstitium in a quiescent state poised to sense and respond to injury by synthesizing and secreting ...
Robert S. Goldsmith +4 more
wiley +1 more source
Farmacogenética en Fibrosis Quística. [PDF]
La fibrosis quística (a partir de ahora referida como FQ) fue descrita por primera vez en 1936 como una entidad separada. También recibía el nombre de “mucoviscidosis” debido a la acumulación de espesas secreciones mucosas que bloqueaban las vías aéreas,
Oraá Pérez, Javier
core

